| Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mucin 1, cell surface associated | ||||
| GTO ID | GTC2147 |
| Trial ID | NCT04025216 |
| Disease | Lung Non-Small Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Multiple Myeloma | Ovarian Cancer | Fallopian Tube Cancer | Triple-Receptor Negative Breast Cancer |
| Altered gene | MUC1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TnMUC1 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers |
| Year | 2019 |
| Country | United States |
| Company sponsor | Tmunity Therapeutics |
| Other ID(s) | CART-TnMUC1-01 |
| Cohort 1 | |||||||||||||||
|
|||||||||||||||